IP Library Granted Patent US 10,557,167
Granted Patent B2
US 10,557,167 · App. 15/448,317 · Granted Feb 11, 2020

Biomolecule sequencing devices, systems and methods

Inventors: Tomoji Kawai (Osaka, JP); Masateru Taniguchi (Osaka, JP); Takahito Ohshiro (Osaka, JP); Mark Oldham (Emerald Hills, CA); Eric Nordman (Palo Alto, CA)
Assignee: QUANTUM BIOSYSTEMS INC.
C12Q1/6869G01N27/04G16B30/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,557,167
App. No.
15/448,317
Granted
Feb 11, 2020
Kind
B2
Abstract

Devices, systems and methods for sequencing protein samples are provided. In some examples, currents generated when a monomer passes through between electrodes of a nanogap electrode pair are measured for each of several different distances, so that monomers are identified when compared to a reference physical quantity of a known monomer, which may be obtained from a current measured with a similar inter-electrode distance(s) at which each of plural kinds of monomers are identifiable and ordered with predetermined accuracy and based on a detected physical quantity obtained from a tunneling current, which may be further normalized by the use of one or more reference substances.

Claims (31)

1. A system for detecting a biomolecule using at least one pair of nanogap electrodes, comprising:

a fluid flow unit comprising at least one pump for directing a plurality of monomers with reference substances bound thereto to the at least one pair of nanogap electrodes, wherein the reference substances comprise a first reference substance bound to a first monomer and a second reference substance bound to a second monomer, wherein the first reference substance is different than the second reference substance; and

a computer processor coupled to the at least one pair of nanogap electrodes and programmed to:

(a) measure tunneling nanocurrent signals resulting from the plurality of monomers with reference substances bound thereto using the at least one pair of nanogap electrodes, wherein the tunneling nanocurrent signals correspond to the reference substances, wherein the first reference substance and the second reference substance correspond to different tunneling nanocurrent signals; and

(b) identify a monomer of the plurality of monomers with reference substances bound thereto based on the tunneling nanocurrent signals measured in (a).

2. The system of claim 1 , wherein the monomer of the plurality of monomers with reference substances bound thereto is identified based upon a reference physical quantity of the monomer.

3. The system of claim 1 , wherein the reference substances are electrically conductive.

4. The system of claim 1 , wherein the tunneling nanocurrent signals of the reference substances are measured for at least about one second.

5. The system of claim 1 , wherein the at least one pair of nanogap electrodes is normalized using the reference substances.

6. The system of claim 1 , wherein the biomolecule is between electrodes of the at least one pair of nanogap electrodes.

7. The system of claim 1 , wherein the monomer of the plurality of monomers with reference substances bound thereto is bound to the biomolecule, and wherein the computer processor is further programmed to detect the reference substances using the tunneling nanocurrent signals measured in (a).

8. The system of claim 1 , wherein the reference substances comprise subunits.

9. The system of claim 1 , wherein the plurality of monomers with reference substances bound thereto comprises native nucleotide bases and/or modified nucleotide bases.

10. The system of claim 1 , wherein the plurality of monomers with reference substances bound thereto is incorporatable.

11. The system of claim 10 , wherein the monomer of the plurality of monomers with reference substances bound thereto comprises a portion of a double stranded nucleic acid.

12. The system of claim 11 , wherein the portion of the double stranded nucleic acid is sequenced.

13. A method of detecting a biomolecule, comprising:

(a) providing a plurality of monomers with reference substances bound thereto, wherein the reference substances comprise a first reference substance bound to a first monomer and a second reference substance bound to a second monomer, wherein the first reference substance is different than the second reference substance;

(b) using at least one pair of nanogap electrodes to measure tunneling nanocurrent signals resulting from the plurality of monomers with reference substances bound thereto, the tunneling nanocurrent signals corresponding to the reference substances, wherein the the first reference substance and the second reference substance correspond with different tunneling nanocurrent signals; and

(c) identifying a monomer of the plurality of monomers with reference substances bound thereto based on the tunneling nanocurrent signals measured in (b).

14. The method of claim 13 , wherein the identifying of the monomer of the plurality of monomers with reference substances bound thereto is based upon a reference physical quantity of the monomer.

15. The method of claim 13 , wherein the reference substances are electrically conductive.

16. The method of claim 13 , wherein the tunneling nanocurrent signals of the reference substances are measured for at least about one second.

17. The method of claim 13 , further comprising normalizing the at least one pair of nanogap electrodes using the reference substances.

18. The method of claim 13 , wherein the biomolecule is between electrodes of the at least one pair of nanogap electrodes.

19. The method of claim 13 , wherein the monomer of the plurality of monomers with reference substances bound thereto is bound to the biomolecule, and wherein the method further comprises detecting the reference substances using the tunneling nanocurrent signals measured in (b).

20. The method of claim 13 , wherein the reference substances comprise subunits.

21. The method of claim 13 , wherein the plurality of monomers with reference substances bound thereto comprises native nucleotide bases and/or modified nucleotide bases.

22. The method of claim 13 , wherein the plurality of monomers with reference substances bound thereto is incorporatable.

23. The method of claim 22 , wherein the monomer of the plurality of monomers with reference substances bound thereto comprises a portion of a double stranded nucleic acid.

24. The method of claim 23 , wherein the portion of the double stranded nucleic acid is sequenced.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2020
From: QUANTUM BIOSYSTEMS INC.
To: OSAKA UNIVERSITY
Reel/Frame 054193/0744 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2017
From: KAWAI, TOMOJI; TANIGUCHI, MASATERU; OHSHIRO, TAKAHITO
To: OSAKA UNIVERSITY
Reel/Frame 043966/0895 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2017
From: OLDHAM, MARK; NORDMAN, ERIC
To: QUANTUM BIOSYSTEMS INC.
Reel/Frame 043966/0901 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2017
From: OSAKA UNIVERSITY
To: QUANTUM BIOSYSTEMS INC.
Reel/Frame 043966/0915 →
Priority Claims (2)
JP 2013-193498 · Sep 18, 2013 · national
JP 2013-197443 · Sep 24, 2013 · national
Continuity (3)
Continuation 15061871 · Mar 4, 2016
Continuation PCTUS2014056173 · Sep 17, 2014
Related Publication 20180023132A1 · Jan 25, 2018